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Abstract Mercury resistance determinants are widespread in
Gram-negative bacteria, but vary in the number and identity of
genes present. We have shown that the merF gene from plasmid
pMER327/419 encodes a 8.7 kDa mercury transport protein, by
determining in vivo mercury volatilisation when MerF is
expressed in the presence of mercuric reductase. We have
confirmed that MerC of Tn21 is also a mercuric ion transporter.
We have been able to detect interaction of the periplasmic protein
MerP only with the MerT transporter, and not with MerF or
MerC. Hydropathy analysis led to the prediction of models for
MerT, MerC and MerF having three, four and two transmem-
brane regions respectively. In all three cases one pair of cysteine
residues is predicted to be within the inner membrane with a
second pair of cysteine residues on the cytoplasmic face, and the
second helix contains a proline and at least one charged residue.
The mechanisms of mercuric ion transport may be similar in
these transporters even though their structures in the membrane
differ.
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1. Introduction
Mercuric ion resistance in Gram-negative bacteria is widely
distributed and is encoded by mer operons, usually located on
transposons or plasmids (for recent reviews see [1^3]). Resis-
tance is due to Hg(II) being taken up into the cell and deliv-
ered to the NADPH-dependent £avoenzyme mercuric reduc-
tase (E.C. 1.16.1.1). Mercuric reductase (MR, the merA gene
product) catalyses the two-electron reduction of Hg(II) to the
volatile low-toxicity Hg(0) [4]. Uptake of Hg(II) ions is re-
quired to confer resistance in vivo and is the rate-limiting
step in resistance encoded by the mer determinants of Tn21
and Tn501 [5,6].
The mer operon of transposon Tn501 from Pseudomonas
aeruginosa encodes two proteins implicated in mercuric ion
transport, merP and merT [7,8]. That from Tn21 encodes an
additional gene merC, located between merP and merA [9,10],
which has been suggested to encode a mercury transport pro-
tein [11], by analogy with the merC gene of Thiobacillus ferro-
oxidans [12,13]. Plasmid pMER327/419 from Pseudomonas
£uorescens [14] also contains an open reading frame, desig-
nated merF, between merP and merA.
The mechanism of protein-mediated transport of mercuric
ions across the bacterial membrane is not yet understood in
any great detail. In Tn501 MerT two cysteines in the ¢rst
transmembrane region are both required for Hg(II) transport
and a second pair of cysteines, located on the cytoplasmic face
of the membrane, are essential to maximal transport [8].
Here we have tested the hypothesis that MerF is a mercuric
ion transport protein, investigated possible interactions of the
known mercuric ion transporters with the periplasmic protein
(MerP), and sought common features between the known
mercuric transport proteins in order to develop further the
model for the transport of Hg(II) across the cytoplasmic
membrane.
2. Materials and methods
2.1. Molecular genetics
Plasmids used in this work are detailed in Table 1. DNA manipu-
lations were carried out according to the methods outlined in [15] in
E. coli TG2 (supE, hsdv5, thi, vlac-proAB, vsrl-recA, 306 : :Tn10,
FP[traD36, proAB, lacIq, lacZvM15]) [16], except expression studies
with pUC18/19-derived plasmids that were performed in E. coli
CSH26vrecA (vlac-proAB, ara, thi, vrecA) [17]. DNA-modifying en-
zymes were purchased from Gibco-BRL, Paisley, UK. The merT,
merP (from Tn501), merF (from pMER327/419) and merC (from
Tn21) genes were cloned directly from other vectors, as outlined in
Table 1, into the multiple cloning sites of either pUC18 or pUC19
vectors, in an orientation such that the expression of the mer gene(s)
was from the lac promoter.
Di¡erences in translation initiation of the merC gene and merF gene
were minimised in volatilisation assays by cloning PCR products in
place of merT in Tn501 and maintaining the merT translation initia-
tion region. Ampli¢cation of merC used Vent1 DNA polymerase
(New England Biolabs, Herts, UK) with primers shown in Table 2
for 24 cycles of: 96‡C, 40 s; 55‡C (cycles 1^3) or 80‡C (cycles 4^24),
60 s; 72‡C, 120 s. For merF ampli¢cation used di¡erent primers (Ta-
ble 2) and 70‡C was used instead of 80‡C for cycles 4^24. The prod-
ucts were cloned into the LspI-BglII linker which replaces the merT
gene in pBRmerBS2vT (Table 1), to produce pBR-C and pBR-F.
Expression of merC or merF was regulated by MerR and co-expressed
with merP, A and D.
2.2. Localisation of merT, merC and merF gene products
A modi¢cation of the ‘maxicell’ method of [18] was used to con¢rm
the expression of the MerC, MerF and MerT proteins and to deter-
mine their subcellular location. Cultures of E. coli CSH26vrecA (pA-
CAH52) containing pUC18/19-derived plasmids were grown to mid-
log phase at 37‡C in M9 medium [17], UV-irradiated and then incu-
bated (37‡C, 1 h) in the dark before adding 1-cycloserine (Sigma
Chemical Co., UK) to 100 WM. Incubation was continued overnight,
cells were harvested, washed and resuspended in M9 salts containing
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10.5% (w/v) cysteine-free assay medium (Difco Laboratories, Detroit,
USA) and 100 WM 1-cycloserine, then 35S-labelled methionine/cysteine
Translabel (2 WCi; ICN, UK) was added. Gene expression was in-
duced for 1 h by addition of IPTG to 1 mM. Cells were harvested,
lysed by sonication and unlysed cells were removed by low speed
centrifugation. Crude membrane fractions were isolated by centrifu-
gation (100 000Ug, 1.5 h) and resuspended in 100 mM Tris^Cl, pH
6.8, 10% glycerol, 0.4% SDS and 1% 2-mercaptoethanol for analysis.
Polyacrylamide slab gel electrophoresis was performed according to
[19]. The gel was dried and a digital image of labelled material was
obtained using a Molecular Dynamics phosphorimager system. A
control periplasmic fraction was obtained from labelled cells by the
MgSO4 method described in [20].
2.3. Mercury volatilisation assays
Mercury volatilisation assays were performed using a method
adapted from [21]. Overnight shake cultures of E. coli TG2 (pBRmer)
or related cells in M9 broth [17] at 37‡C were diluted into fresh M9
medium and grown to mid-log phase. Expression of the mer genes was
induced with 1 Wg ml31 HgCl2 for 1 h, cells were harvested and a
constant number of cells (approximately 2U108) were resuspended in
100 Wl of M9 medium supplemented with 5 WM HgCl2 and 1 mM
IPTG.
The cell suspension was transferred to 5 ml of the same bu¡er
containing 203Hg (1 WCi ml31 ; Amersham, UK) and incubated with
shaking at 37‡C. Timed 100 Wl aliquots were transferred to scintilla-
tion £uid (5 ml; Optiphase Hisafe, Wallac, Finland) and the amount
of 203Hg was quanti¢ed by scintillation counting.
2.4. Computer analysis of protein sequences
DNA and peptide sequence data were analysed using the GCG
suite of programs (Version 10.0, Genetics Computer Group, Madison,
WI, USA). Secondary structure motifs were identi¢ed from the hydro-
pathy algorithms PEPTIDESTRUCTURE, from the GCG suite, and
the transmembrane helix identi¢cation program DAS [22].
3. Results
3.1. Localisation of merT, merC and merF gene products
Membrane fractions from E. coli CSH26vrecA cells ex-
pressing the merTP, merT, merC, or merF genes in pUC18/
19 contained radiolabelled protein of the molecular masses
expected from their primary structures (Fig. 1), except MerT
which runs at a higher apparent Mr, as found previously
[8,23^25]. The MerC and MerF proteins (tracks 4 and 5,
Fig. 1) have Mr values of 15 000 and 8700 respectively. A
periplasmic fraction prepared from the same cells showed no
proteins of equivalent size (data not shown) indicating that
these are not transient periplasmic proteins. MerF was less
well expressed than the other proteins and the longer incuba-
tion with 35S gives additional labelled proteins from MerF-
containing cells. The reasons for the lower apparent expres-
sion of MerF (e.g. expression, membrane incorporation or
protein turnover) were not addressed in the present study.
MerC and MerF showed better expression when expressed
from the MerT translation initiation region than when ex-
pressed using their own initiation sequences (data not shown).
3.2. Mercury volatilisation
E. coli TG2 (pBRmer) cells containing the merT, merTP,
merC, or merF genes cloned in pBRmer showed an increase
in mercury volatilisation compared to cells containing
pBRmervT (Fig. 2). Volatilisation was lower than in an equiv-
alent amount of sonicated cell-free extract, indicating that in
each case transport was rate-limiting for resistance. The high-
est rate of cellular mercury volatilisation was produced when
both MerT and MerP were expressed, with MerT alone giving
approximately 20% less volatilisation. MerC showed greater
Table 1
Plasmids used in this study
Plasmid Relevant featuresa or description Reference or
source
pUC18 ApR ; multiple cloning site adjacent to lac promoter [30]
pUC19
pACAH52 pACYC184-derived plasmid constitutively expressing merA from the CAT promoter [5]
pBR322 ApR [31]
pBRmer BS2 ApR ; 4.3 kb EcoRI/NruI fragment containing merRTPAD genes of Tn501 subcloned from
pUB3466BS2 [8] into the EcoRI/NruI sites of pBR322
This work
pBRmerBS2vP ApR ; BglII/BamHI deletion of merP from pBRmerBS2 This work
pBRmerBS2vT ApR ; pBRmerBS2 cut with LspI and BglII to remove the merT gene and replaced with a
LspI/BglII linker
This work
pBR-C ApR ; merC from pUC19C cloned into the LspI/BglII sites of pBRmerBS2vT vector; giving
merRCPAD
This work
pBR-CvP ApR ; BglII/BamHI deletion of merP from pBR-C This work
pBR-F ApR ; merF from pUC18F cloned into the LspI/BglII sites of pBRmerBS2vT; giving merRFPAD This work
pBR-FvP ApR, BglII/BamHI deletion of merP from pBR-F This work
pUC18TP merT and merP cloned from pT7ScmerTP [32] into the EcoRI/BamHI sites of pUC18 This work
pUC18T BglII/BamHI deletion of merP from pUC18TP This work
pUC19C 1652 bp NheI/EcoRI DNA fragment containing merC cloned from pDU1205 [33] into pUC13
XbaI/EcoRI and subcloned as a PstI/EcoRI fragment into the PstI/EcoRI sites of pUC19
This work
pUC18F 380 bp KpnI/XmnI fragment containing merF subcloned from pDGJ118 [34] into the KpnI/HincII
sites in pUC18
This work
aAp, ampicillin; CAT, chloramphenicol acetyl transferase.
Table 2
PCR primers for ampli¢cation of merC and merF
Primer Sequencea
merC (SDmerT) 5P-TTCGAAAGGACAAGCGCATGGGACTGATGA-
CACGC-3P
merC (rev) 5P-AGATCTCCGATCACAAGCGCTTGGC-3P
merF (SDmerT) 5P-TTCGAAAGGACAAGCGCATGAAAGACCCGA-
AGAC-3P
merF (rev) 5P-AGATCTCCGATCATTTTTTTACTCCATTGA-
ATTTGG-3P
aRestriction endonuclease sites are given in italics (LspI, TTCGAA;
BglII, AGATCT), the Shine-Dalgarno sequence of the MerT trans-
lation initiation region is in bold and the start codon is underlined.
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volatilisation than MerF, but neither MerC nor MerF showed
any increase in the rate of mercury volatilisation in the pres-
ence of MerP. Interestingly, the expression of MerP and
MerA in the absence of MerT, MerC or MerF gave a higher
level of volatilisation than the strain expressing MerA alone.
3.3. Analysis of protein sequences of MerT, MerC and MerF
Hydropathy prediction programs indicated that MerT has
three membrane-spanning regions, MerC has four and MerF
has two (Fig. 3A); the ¢rst region in each case containing two
closely spaced cysteine residues and a nearby distal proline
residue (Fig. 3B). The second hydrophobic region contains
one or more charged residues, with an adjacent proline (Fig.
3B). Each protein also contains an additional pair of cysteine
residues predicted to be on the cytoplasmic face of the mem-
brane, as they are found in regions containing positive charges
(Fig. 3B). In MerT this is located between transmembrane
regions II and III and in MerC and MerF this is close to
the carboxyl-terminal (Fig. 3A).
4. Discussion
4.1. Identi¢cation of mercury transport genes
The data reported here indicate that MerF and MerC are
bona ¢de mercuric ion transport proteins which carry Hg(II)
to mercuric reductase. In vivo expression of MerF in the
presence of reductase gives increased volatilisation over an
isogenic strain lacking the merF gene, although the phenotypic
e¡ects are less pronounced than for MerC, or for MerT and
MerTP. Although the role of Tn21 MerC has previously been
deduced by comparison with the MerC of T. ferro-oxidans
and uptake has been demonstrated [12,13], this is the ¢rst
time its transport rather than binding properties [26,27] have
been demonstrated. Our data on MerT and MerP agree with
earlier observations [8].
The signi¢cance of di¡erences in quantitative e¡ects of ex-
pression of MerT ( þ MerP), MerC and MerF is di⁄cult to
determine. The expression of the transport proteins was likely
to be di¡erent in pUC vectors, as their own translation ini-
tiation regions were used, and some evidence for this came
from ‘maxicell’ labelling experiments (Fig. 1) in which the
MerF product was always present in much lower amounts
than MerT or MerC. When the transport proteins were ex-
pressed in pBRmer derivatives, MerT, MerC and MerF were
all expressed from the translation initiation region of MerT up
to the initiation codon, and are apparently produced in sim-
ilar amounts (data not shown), but they may a¡ect the down-
stream expression of the mercuric reductase in this case. Such
expression di¡erences are di⁄cult to control, but do not a¡ect
the qualitative observations.
We have previously shown that MerP and MerT together
are more e⁄cient in mercuric ion uptake and volatilisation
than MerT alone [8]; however, we show here that MerP
makes no apparent di¡erence to the rate of volatilisation in
the presence of MerC or MerF, indicating that neither of
these transport proteins interacts with MerP in vivo. Trans-
port is rate-limiting for volatilisation, as shown using a cell-
free extract. The volatilisation activity therefore represents the
rate of mercuric ion transport of the di¡erent mer proteins.
Expression of MerP and mercuric reductase (in the absence
of MerT, MerC or MerF) gives a slightly higher rate of vol-
atilisation than the expression of mercuric reductase alone
(Fig. 2, pBRmerBS2vT and pBRmerBS2vTP). The reasons
for this are not clear, but MerP may increase the local con-
centration of mercuric ions in the periplasmic compartment
and allow increased transmembrane passage of partially co-
valent Hg(II) compound. Any e¡ects must be subtle as there is
no detectable e¡ect of MerP in the presence of MerC or
MerF, and can be di¡erentiated from the pronounced e¡ect
of MerP on transport by MerT. Unlike MerT, MerC or
MerF, MerP does not cause increased sensitivity to HgCl2
in the absence of mercuric reductase, or increased resistance
in its presence, when measured by minimum inhibitory con-
centration (data not shown), indicating that MerP does not
act to transport Hg(II) directly.
4.2. A unitary model for mercuric ion transport
The hydropathy prediction programs indicated that the
numbers of membrane-spanning regions in the three proteins
are di¡erent: MerT-3; MerC-4; MerF-2 (Fig. 3A). Each pro-
Fig. 2. Assay showing the volatilisation of Hg(II) from cultures of
E. coli TG2 cells containing pBRmer and its derivatives. The
amount of 203Hg remaining in the assay bu¡er at each time point
was subtracted from the initial value and expressed as a percentage
of initial 203Hg. Each sample was assayed in triplicate and all assays
were done in parallel. The symbols are: cells containing pBRmerBS2
(F), pBRmerBS2vP (E), pBRmerBS2vT (b), pBRmerBS2vTP (a),
pBR-C (R), pBR-CvP (O), pBR-F (8), pBR-FvP (7) and
pBR322 (*).
Fig. 1. SDS^polyacrylamide gel electrophoresis of 35S-labelled pro-
teins from membrane fractions. The tracks are (1) 14C molecular
weight markers (Amersham, UK) with sizes in kDa; membrane
fractions from E. coli CSH26vrecA (pACAH52) cells containing: (2)
pUC18; (3) pUC18TP; (4) pUC18T; (5) pUC19C; (6) pUC18F. Ar-
rows mark the proteins MerT (and a trace of MerP), MerT, MerC
and MerF in tracks 3^6.
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Fig. 3. The conserved features of the MerT, MerC and MerF proteins and alignment of key elements. A: Output of PEPTIDESCAN hydropa-
thy plots. B: Topological alignment of all amino acids separated according to the predicted hydrophobic (membrane-spanning) elements. C:
Structural elements of the transporters aligned according to the predicted topology: the cysteines in the ¢rst transmembrane region and in the
cytoplasmic regions of MerT, MerF and MerC are boxed, as are the charged residues in the second transmembrane region; prolines in the ¢rst
and second transmembrane region are underlined and in bold.
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tein has a cysteine pair located in the ¢rst transmembrane
region: Cys-Cys in MerT and MerF, and Cys-Ala-Ala-Cys
in MerC (Fig. 3B). Given the structure of an K-helix, the
two types of motif may not represent signi¢cant chemical
di¡erences. There is a clear evidence from mutagenesis studies
on MerT [8] and MerC (this work and [26]) that these cysteine
residues are required for mercuric ion transport. We predict
that they are also required in MerF.
Proline residues are conserved on the carboxy-terminal side
of this cysteine motif and may also be of structural impor-
tance, perhaps serving to expose the Cys residues to solvent,
as may the proline residue(s) in the second transmembrane
regions (Fig. 3B). In all three proteins a charged residue is
located to the periplasmic side of this second proline residue.
We propose that a charged or polar residue within this region
is important for transport. This has been con¢rmed for MerT
(Leang, Brown and Wilson, in preparation).
The other major structurally equivalent region identi¢ed for
each protein is a cysteine pair on the cytoplasmic face of the
protein, shown in Fig. 3. In all three proteins this region
contains a high proportion of charged residues, including pos-
itively charged amino acids, and this region may be involved
in the transfer of mercuric ions to the N-terminal domain in
MR [28,29], as mutation of these cysteine residues in MerT
causes a reduction in mercuric ion transport [8].
From these analyses we conclude that MerT, MerC and
MerF may function by equivalent mechanisms, with mer-
cury-binding cysteines within the transmembrane helix, ex-
posed to the periplasmic compartment, and functional cys-
teines on the cytoplasmic face of the inner membrane. The
e¡ect of the di¡erent number of transmembrane regions is not
known; they may a¡ect the stability of the transport proteins
in the membrane or the formation of an oligomeric complex.
The MerF monomer is one of the smallest gene products
known which constitutes a transport system.
Although our data show that the merT, merC and merF
genes all encode mercuric ion transport genes and we hy-
pothesise that their mechanisms of action are similar, we
have already shown di¡erences in their interactions with
MerP and cannot yet address the reasons why the merC and
merF genes are found in some operons but not others. It is
entirely possible that the Km for Hg(II) is di¡erent for each of
the transporters, permitting e⁄cient mercuric ion resistance at
di¡erent Hg(II) concentrations. Testing this hypothesis will
require the separate overproduction and partial puri¢cation
of each of the transport proteins.
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